Phase I trial assessing safety and pharmacokinetics of afatinib (BIBW 2992) with intravenous weekly vinorelbine in advanced solid tumors.
R. Bahleda
No relevant relationships to disclose
J. Soria
Consultant or Advisory Role - Boehringer Ingelheim
Y. Berge
No relevant relationships to disclose
C. Massard
No relevant relationships to disclose
S. Wind
Employment or Leadership Position - Boehringer Ingelheim
M. M. Uttenreuther-Fischer
Employment or Leadership Position - Boehringer Ingelheim
F. Fleischer
Employment or Leadership Position - Boehringer Ingelheim
H. De-Montserrat
Employment or Leadership Position - Boehringer Ingelheim
F. Solca
Employment or Leadership Position - Boehringer Ingelheim
I. Tschoepe
Employment or Leadership Position - Boehringer Ingelheim
J. Delord
Consultant or Advisory Role - Roche